Looking at the universe of stocks we cover at Dividend Channel, on 3/13/17, C & F Financial Corp. (CFFI) will trade ex-dividend, for its quarterly dividend of $0.33, payable on 4/1/17. As a percentage of CFFI's recent stock price of $46.60, this dividend works out to approximately 0.71%, so look for shares of C & F Financial Corp. to trade 0.71% lower — all else being equal — when CFFI shares open for trading on 3/13/17.Below is a dividend history chart for CFFI, showing historical dividends prior to the most recent $0.33 declared by C & F Financial Corp.: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CFFI is likely to continue, and whether the current estimated yield of 2.83% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of CFFI shares, versus its 200 day moving average: Looking at the chart above, CFFI's low point in its 52 week range is $37.05 per share, with $53.40 as the 52 week high point — that compares with a last trade of $46.60. In Thursday trading, C & F Financial Corp. shares are currently trading flat on the day.
More from Stocks
Tesla, CVS, Google and the Federal Reserve - 5 Things You Must Know
U.S. stock futures point to a weaker start for Wall Street on Wednesday, though there are increasing signs of tangible progress in U.S.-China trade talks; CVS and Avis report earnings; Elon Musk says Tesla will have the technology in place for a self-driving car by the end of the year.
Jim Cramer's Worried About Amazon and Apple and Their 'Achilles Heel' Statuses
Jim Cramer explains why he's worried about two of the FANG names. Hint: Divorce and Huawei.
Teva Slips After 'Pay-For-Delay' Settlement with US Federal Trade Commission
Teva Pharmaceuticals shares were indicated lower in pre-market trading Wednesday after the drugmaker reached a settlement with the Federal Trade Commission over allegations it delayed the release of generic medicines through agreements with pharmaceutical rivals.
Walmart Faces Challenge to UK Merger Plans as CMA Questions Asda-Sainsburys Deal
Walmart struggling U.K. subsidiary could be blocked from merging with a larger rival over concerns from the country's competition watchdog that the tie-up would lead to higher prices and a "poorer experience" for shoppers in Europe's second-largest market.